At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Early Anti-inflammatory Treatment in Patients With Acute ACL Tear
In Brief
A Phase 2 clinical trial evaluating Kenalog or placebo, Kenalog then Placebo, and 2 other interventions for Anterior Cruciate Ligament (ACL) Tears. Completed, enrolled 49 participants across 1 site.
Detailed Summary
This research study is the first of its kind and will allow health care professionals and researchers to answer many questions about the reasons why anterior cruciate ligament (ACL) injury leads to knee pain and disability and osteoarthritis. We also hope that this study will be the beginning of new, more powerful and safer drugs to help patients with ACL injuries heal sooner and return to sports or daily activities pain free. Study participants will be recruited from the University of Kentucky and Vanderbilt University. The purpose of this research is to gather information on how safe and effective Kenalog® is in alleviating knee pain following ACL rupture.